137 related articles for article (PubMed ID: 37242684)
1. Discovery of Novel Thiophene/Hydrazones: In Vitro and In Silico Studies against Pancreatic Cancer.
Coskun GP; Ozhan Y; Dobričić V; Bošković J; Reis R; Sipahi H; Sahin Z; Demirayak S
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242684
[TBL] [Abstract][Full Text] [Related]
2. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Adl K; Sakr H; Nasser M; Alswah M; Shoman FMA
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000079. PubMed ID: 32515896
[TBL] [Abstract][Full Text] [Related]
3. Investigations of
Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
[TBL] [Abstract][Full Text] [Related]
4. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
[TBL] [Abstract][Full Text] [Related]
5. An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and
Afzal O; Ahsan MJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202650
[TBL] [Abstract][Full Text] [Related]
6. Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with
Yasin M; Shahid W; Ashraf M; Saleem M; Muzaffar S; Ejaz SA; Mahmood HMK; Bhattarai K; Riaz N
J Biomol Struct Dyn; 2023 Jul; 41(11):5166-5182. PubMed ID: 35699270
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors.
El-Adl K; Ibrahim MK; Khedr F; Abulkhair HS; Eissa IH
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100278. PubMed ID: 34596910
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
10. Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition.
Chandel P; Kumar A; Singla N; Kumar A; Singh G; Gill RK
Medchemcomm; 2019 Mar; 10(3):421-430. PubMed ID: 30996860
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling studies, ADME prediction of arachidonic acid carbamate derivatives, and evaluation of their acetylcholinesterase activity.
Kalin TN; Kilic D; Arslan F; Colak O; Altundas A
Drug Dev Res; 2020 Apr; 81(2):232-241. PubMed ID: 31758816
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activity evaluation of novel imidazopyridine carbohydrazide derivatives.
Firouzi M; Haghighijoo Z; Eskandari M; Mohabbati M; Miri R; Jamei MH; Poustforoosh A; Nazari S; Firuzi O; Khoshneviszadeh M; Edraki N
BMC Chem; 2024 Jan; 18(1):6. PubMed ID: 38184605
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
16. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
17. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.
Pedrood K; Rezaei Z; Khavaninzadeh K; Larijani B; Iraji A; Hosseini S; Mojtabavi S; Dianatpour M; Rastegar H; Faramarzi MA; Hamedifar H; Hajimiri MH; Mahdavi M
BMC Chem; 2022 Jul; 16(1):57. PubMed ID: 35909126
[TBL] [Abstract][Full Text] [Related]
19. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent EGFR Inhibitors With
Li M; Xue N; Liu X; Wang Q; Yan H; Liu Y; Wang L; Shi X; Cao D; Zhang K; Zhang Y
Front Pharmacol; 2021; 12():647591. PubMed ID: 34122069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]